TY - JOUR
KW - Analgesics, Opioid/administration & dosage/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Health Services Accessibility
KW - Humans
KW - Medicaid/legislation & jurisprudence/statistics & numerical data
KW - Methadone/therapeutic use
KW - Opiate Substitution Treatment/statistics & numerical data
KW - Opioid-Related Disorders/drug therapy
KW - Patient Protection and Affordable Care Act/legislation & jurisprudence
KW - Physicians/statistics & numerical data
KW - Socioeconomic Factors
KW - United States
KW - Medicaid expansion
KW - buprenorphine
KW - Methadone
KW - opioid use disorder
AU - A. K. Gertner
AU - A. G. Robertson
AU - H. Jones
AU - B. J. Powell
AU - P. Silberman
AU - M. E. Domino
A1 - 
AD - Department of Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.; Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Carrboro, North Carolina.; Brown School, Washington University in St. Louis, St. Louis, Missouri.; Department of Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.; Department of Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.
BT - Health services research
C5 - Financing & Sustainability; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
CP - 3
DO - 10.1111/1475-6773.13282
IS - 3
JF - Health services research
LA - eng
M1 - Journal Article
PY - 2020
SN - 1475-6773; 0017-9124; 0017-9124
SP - 383
EP - 392
EP - 
T1 - The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints
T2 - Health services research
TI - The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints
U1 - Financing & Sustainability; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
U2 - 32166761
U3 - 10.1111/1475-6773.13282
VL - 55
VO - 1475-6773; 0017-9124; 0017-9124
Y1 - 2020
Y2 - Jun
ER -